Comment
doi: 10.1093/infdis/173.6.1524.
Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease
- PMID: 8648237
- DOI: 10.1093/infdis/173.6.1524
Item in Clipboard
Comment
Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease
J Infect Dis.
1996 Jun.
No abstract available
Comment on
-
Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy.J Infect Dis. 1995 Nov;172(5):1238-45. doi: 10.1093/infdis/172.5.1238. J Infect Dis. 1995. PMID: 7594659
Similar articles
-
Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy.J Infect Dis. 1995 Nov;172(5):1238-45. doi: 10.1093/infdis/172.5.1238. J Infect Dis. 1995. PMID: 7594659
-
Conference looks at HIV drug resistance.GMHC Treat Issues. 1995 Sep;9(9):6-8. GMHC Treat Issues. 1995. PMID: 11362910
-
Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".AIDS. 2008 Jan 2;22(1):165-7. doi: 10.1097/QAD.0b013e3282f2be42. AIDS. 2008. PMID: 18090413 Review. No abstract available.
-
[Resistance to protease inhibitors].Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):34-41. Enferm Infecc Microbiol Clin. 2001. PMID: 11428058 Review. Spanish. No abstract available.
-
New protease drug shows early promise.BETA. 1995 Sep:27, 33. BETA. 1995. PMID: 11362887
Cited by
-
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects.Br J Clin Pharmacol. 2002 Sep;54(3):262-8. doi: 10.1046/j.1365-2125.2002.01663.x. Br J Clin Pharmacol. 2002. PMID: 12236846 Free PMC article.
-
Amprenavir: a review of its clinical potential in patients with HIV infection.Drugs. 2000 Dec;60(6):1383-410. doi: 10.2165/00003495-200060060-00012. Drugs. 2000. PMID: 11152018 Review.
-
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding.Antimicrob Agents Chemother. 2001 Oct;45(10):2746-54. doi: 10.1128/AAC.45.10.2746-2754.2001. Antimicrob Agents Chemother. 2001. PMID: 11557464 Free PMC article.
-
TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates.Antimicrob Agents Chemother. 2005 Jun;49(6):2314-21. doi: 10.1128/AAC.49.6.2314-2321.2005. Antimicrob Agents Chemother. 2005. PMID: 15917527 Free PMC article.
-
Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.Antimicrob Agents Chemother. 2004 Aug;48(8):2911-7. doi: 10.1128/AAC.48.8.2911-2917.2004. Antimicrob Agents Chemother. 2004. PMID: 15273100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
